Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Parkinson's Disease: We Care!

Bloem BR, Brundin P.

J Parkinsons Dis. 2020;10(s1):S1-S3. doi: 10.3233/JPD-209003.

Early-Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation

Kim CY, Wirth T, Hubsch C, Németh AH, Okur V, Anheim M, Drouot N, Tranchant C, Rudolf G, Chelly J, Tatton-Brown K, Blauwendraat C, Vonsattel JPG, Cortes E, Alcalay RN, Chung WK.

Ann Neurol. 2020 Nov;88(5):1028-1033. doi: 10.1002/ana.25863. Epub 2020 Aug 22.

An elderly man with normal pressure hydrocephalus presenting with asymmetric parkinsonism in the upper and lower extremities

Ahn BJ, Lee M, Ju H, Im K, Kwon KY.

Geriatr Gerontol Int. 2020 Aug;20(8):791-792. doi: 10.1111/ggi.13940.

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease

Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL 3rd, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B; Systemic Synuclein Sampling Study.

Neurology. 2020 Sep 1;95(9):e1267-e1284. doi: 10.1212/WNL.0000000000010404. Epub 2020 Aug 3.

Regulation of Social Stress and Neural Degeneration by Activity-Regulated Genes and Epigenetic Mechanisms in Dopaminergic Neurons

Kent C, Agrawal P.

Mol Neurobiol. 2020 Nov;57(11):4500-4510. doi: 10.1007/s12035-020-02037-7. Epub 2020 Aug 3.

Therapy of Parkinson's Disease Subtypes

Marras C, Chaudhuri KR, Titova N, Mestre TA.

Neurotherapeutics. 2020 Oct;17(4):1366-1377. doi: 10.1007/s13311-020-00894-7.

Parkinson's: A Disease of Aberrant Vesicle Trafficking

Singh PK, Muqit MMK.

Annu Rev Cell Dev Biol. 2020 Oct 6;36:237-264. doi: 10.1146/annurev-cellbio-100818-125512. Epub 2020 Aug 4.

The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction

Szatmári S Jr, Ajtay A, Oberfrank F, Dobi B, Bereczki D.

PLoS One. 2020 Aug 4;15(8):e0236728. doi: 10.1371/journal.pone.0236728. eCollection 2020.

[Advanced Parkinson's disease characteristics in clinical practice: Results from the OBSERVE-PD study and sub-analysis of the Hungarian data]

Takáts A, Aschermann Z, Vécsei L, Klivényi P, Dézsi L, Zádori D, Valikovics A, Varannai L, Onuk K, Kinczel B, Kovács N.

Ideggyogy Sz. 2020 Jul 30;73(7-08):261-268. doi: 10.18071/isz.73.0261.

Where and how alpha-synuclein pathology spreads in Parkinson's disease

Wakabayashi K.

Neuropathology. 2020 Oct;40(5):415-425. doi: 10.1111/neup.12691. Epub 2020 Aug 4.

Anti-Apoptotic Effects of Carotenoids in Neurodegeneration

Park HA, Hayden MM, Bannerman S, Jansen J, Crowe-White KM.

Molecules. 2020 Jul 29;25(15):3453. doi: 10.3390/molecules25153453.

Primary Central Nervous System Lymphoma Presenting as Parkinsonism with Atypical MRI Findings and Elevated 14-3-3 Protein

Nagarajan E, Yerram SY, Digala LP, Bollu PC.

J Neurosci Rural Pract. 2020 Jul;11(3):492-494. doi: 10.1055/s-0040-1713300. Epub 2020 Jun 16.

Assessment of patients with lower urinary tract symptoms where an undiagnosed neurological disease is suspected: A report from an International Continence Society consensus working group

Roy HA, Nettleton J, Blain C, Dalton C, Farhan B, Fernandes A, Georgopoulos P, Klepsch S, Lavelle J, Martinelli E, Panicker JN, Radoja I, Rapidi CA, Pereira E Silva R, Tudor K, Wagg AS, Drake MJ.

Neurourol Urodyn. 2020 Nov;39(8):2535-2543. doi: 10.1002/nau.24469. Epub 2020 Aug 4.

'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine

Rota S, Boura I, Batzu L, Titova N, Jenner P, Falup-Pecurariu C, Chaudhuri KR.

Expert Rev Neurother. 2020 Sep;20(9):953-965. doi: 10.1080/14737175.2020.1806059. Epub 2020 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias